Loading company…
PlusVitech develops treatments for cancer and COVID-19 by repositioning existing pharmaceuticals.
Founded in 2013 and based in Sevilla, Spain, PlusVitech develops treatments for cancer and COVID-19, including therapies based on repositioned pharmaceuticals. Its cancer treatments are undergoing clinical trials. In December 2025, the company received EUR 2.5 million in grant funding from Center for Technological & Industrial Development, part of a larger EUR 3.05 million equity and grant funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in